Join
Live feed
·
INSIDERFilingvia Quantisnow
Merrimack Pharmaceuticals Inc. logo

SEC Form 4: Ray Russell T sold $3,840 worth of shares (1,000 units at $3.84), closing all direct ownership in the company

ByQuantisnow·Wall Street's wire, on your screen.
MACK· Merrimack Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MACK (Merrimack Pharmaceuticals Inc.) and more on Quantisnow.